纵横研报
Ticker Detail

688046.SHG

¥28.81+17.02% 药康生物 Biotechnology
00Reports China 医疗健康
Gempharmatech Co. Ltd. A
医疗健康 · 生物科技

GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, disease mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company has a strategic alliance with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. The company was founded in 2017 and is headquartered in Nanjing, China.

MARKET 市值 10.29B CNY PE 62.8x 52W ¥12.75 – ¥26.33 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 21.8% ROE 7.2% 营业利润率 24.9% 净利润率 19.2%
ANALYST 股息率 0.91%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制